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Summary Photodynamic therapy (PDT) is currently under investigation in phase II and III clinical studies
for the treatment of tumours in superficial localisations. Thus far, the underlying mechanisms of PDT
regarding cellular responses and gene regulation are poorly understood. Photochemically generated singlet
oxygen (102) is mainly responsible for cytotoxicity induced by PDT. If targeted cells are not disintegrated,
photo-oxidative stress leads to transcription and translation of various stress response and cytokine genes.
Tumour necrosis factor (TNF) a, interleukin (IL) 1 and IL-6 are strongly induced by photodynamic treatment,
supporting inflammatory action and immunological anti-tumour responses. To investigate the first steps of gene
activation, this study focused on the proto-oncogenes c-jun and c-fos, both coding for the transcription factor
activator protein 1 (AP-1), which was found to mediate IL-6 gene expression. We here determine the effects of
photodynamic treatment on transcriptional regulation and DNA binding of transcription factor AP-1 in order
to understand the modulation of subsequent regulatory steps. Photodynamic treatment of epithelial HeLa cells
was performed by incubation with Photofrin and illumination with 630 nm laser light in vitro. Expression of
the c-jun and c-fos genes was determined by way of Northern blot analysis, and DNA-binding activity of the
transcription factor AP-1 was evaluated by electrophoretic mobility shift assay (EMSA). Photofrin-mediated
photosensitisation of HeLa cells resulted in a rapid and dose-dependent induction of both genes but
preferential expression of c-jun. Compared with the transient expression of c-jun and c-fos by phorbol ester
stimulation, photodynamic treatment led to a prolonged activation pattern of both immediate early genes.
Furthermore, mRNA stability studies revealed an increased half-life of c-jun and c-fos transcripts resulting
from photosensitisation. Although mRNA accumulation after PDT was stronger and more prolonged
compared with phorbol ester stimulation, with regard to AP-1 DNA-binding activity, phorbol ester was more
efficient. Surprisingly, in addition to the activation of AP-1 DNA-binding via PDT, photodynamic treatment
can decrease AP-1 DNA-binding of other strong inducers, such as the protein kinase C-mediated pathway of
phorbol esters and the antioxidant pyrrolidine dithiocarbamate (PDTC). This study demonstrates a strong
induction of c-jun and c-fos expression by PDT, with prolonged kinetics and mRNA stabilisation as compared
with activation by phorbol esters. Interestingly, this observation is not coincident with an overinduction of AP-
1 DNA-binding, hence suggesting that post-translational modifications are dominant regulatory mechanisms
after PDT that tightly control AP-1 activity in the nucleus thus limiting the risk of deregulated oncogene
expression.
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Photodynamic therapy (PDT) is a novel therapeutic approach
consisting of topical or systemic application of a photo-
sensitising agent and activation by subsequent illumination
with tissue-penetrating visible light. The combination of drug
uptake in malignant tissue and selective light delivery
provides an effective tumour therapy with efficient cytotoxi-
city and minimal damage to normal tissue (Pass, 1993).
Oxidative stress caused by singlet oxygen ('02) iS
responsible for the effects induced by PDT (Weishaupt et
al., 1976). Photosensitisation activates expression of a variety
of stress-response genes coding for heat shock proteins,
glucose-regulated proteins and haem oxygenase (Gomer et
al., 1991; Ryter et al., 1991). The exact functions of these
stress proteins are still unclear; however, they might
participate in a protective reaction to oxidative stress. Evans
et al. (1990) demonstrated the dose-dependent production of
murine tumour necrosis factor (TNF) in supernatants
obtained from PDT-treated macrophages in vitro. Further-
more, interleukin (IL) 6 (Kick et al., 1995) and IL-la/: (G
Kick et al., manuscript submitted) protein synthesis induced
by PDT in epithelial cell lines was recently discovered. These
cytokines have the ability to up-regulate anti-tumour
responses and may be good candidates to mediate the local
inflammatory reaction. In studying molecular mechanisms of
PDT-induced IL-6 expression at the level of gene regulation,
electrophoretic mobility shift assays (EMSAs) revealed
increased AP-1 DNA-binding activity at the distal AP-1
element of the IL-6 promoter (Kick et al., 1995).
To elucidate further the underlying regulation, the present
study analysed the effect of PDT on the AP-1 transcription
factor genes c-jun and c-fos, which are known as proto-
oncogenes. Both genes are members of a multigene family
coding for transcription factors (Curran and Franza, 1988;
Ryder et al., 1989). By interaction of their leucine zipper
domain, Jun and Fos proteins form dimeric complexes
(Sassone-Corsi et al., 1988; Landschulz et al., 1988;
Kouzarides and Ziff, 1988; Gentz et al., 1989). This mode
of dimerisation is a characteristic feature of the bZIP family,
which includes Jun-, Fos-, activating transcription factor
(ATF), cAMP-responsive element-binding (CREB) proteins
and others that can bind to the AP-1 DNA motifs and
closely related sequence elements (Ivashkiv et al., 1990; Hai
and Curran, 1991; Kerppola and Curran, 1993; Hsu et al.,
1994; Kataoka et al., 1995), and are regulated by
phosphorylation and redox changes (Abate et al., 1990;
Boyle et al., 1991; Hunter and Karin, 1992; Derijard et al.,
1994; Kallunki et al., 1994; Kyriakis et al., 1994). AP-1
DNA-binding is considered to be a crucial event in the
transcriptional regulation of a variety of genes associated
with growth, differentiation, cellular stress and tumorigenesis
(Angel and Karin, 1991; Morgan and Curran, 1991;
Holbrook and Fornace, 1991; Saez et al., 1995).
Studying the regulation of this ubiquitous transcription
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factor in response to singlet oxygen was a further reason for
the present investigation, as in vitro photosensitisation by
Photofrin is a system that generates this reactive oxygen
intermediate (Gollnick, 1968; Weishaupt et al., 1976).
Moreover, proto-oncogene expression could be a relevant
aspect ofcancertherapy. Recent studies describe c-jun and c-fos
expression as associated with programmed cell death (Smeyne
et al., 1993; Manome et al., 1993; Kim and Beck, 1994),
multidrug-resistant phenotype (Scanlon et al., 1994), and
deregulated expression has been discussed as a prerequisite of
theirtransformingpotential(Miller etal., 1984; Bos etal., 1990;
Lee et al., 1988; van den Berg et al., 1993).
Materials and methods
Cell line and culture conditions
The human epithelial carcinoma cell line HeLa was grown in
adherent culture in Dulbecco's modified Eagle medium
(DMEM), supplemented with 10% heat complement-
inactivated fetal calf serum (FCS) and 1% penicillin/
streptomycin (all purchased from Gibco-BRL, Eggenstein,
Germany). For the experiments, HeLa cells were removed by
trypsinisation, then washed with phosphate-buffered saline
(PBS) and transferred to 5 cm Petri dishes containing
medium with only 0.5% FCS. Cells were cultured in a
humidified atmosphere at 37'C and 5% carbon dioxide.
Reagents
Pyrrolidine dithiocarbamate (PDTC) was dissolved in PBS as
a 1 M stock solution. N-acetyl-L-cysteine (NAC) was
dissolved in water and adjusted to pH 7.4 by the addition
of sodium hydroxide. Both solutions were prepared
immediately before use. PDTC, NAC, 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), cycloheximide (CHX) and actino-
mycin D (act-D) were purchased from Sigma (Deisenhofen,
Germany). Photofrin (Cyanamid Lederle, Wolfratshausen,
Germany) was aliquoted at 2.5 mg ml-' stock solution and
stored at -20°C.
Photodynamic treatment
Photofrin, a haematoporphyrin derivative preparation, was
used as a photosensitiser. HeLa cells were incubated with
Photofrin 1 h before illumination, appropriate for an almost
complete Photofrin uptake (Leunig et al., 1994). Light
application on the monolayers was performed via a 600 ,um
optical fibre by an argon-pumped dye laser (Aesculap
Meditech, Heroldsberg, Germany) at a wavelength of
630 nm. This light application system was modified to
maintain a homogeneous power density throughout the
diameter of the plate. Power density and homogeneity of
illumination were continuously controlled by a calibrated
power meter (Coherent, Frankfurt am Main, Germany). At a
constant power density of 40 mW cm-2 up to 400 s, thermal
effects upon illumination could be excluded. As determined
24 h after PDT by the trypan blue exclusion method, viability
of cells was higher than 80% at all concentrations of
Photofrin used up to 2 jig ml-1 and treated by a light dose
of 4 J cm-2 as well as under co-treatment.
RNA isolation and Northern blot analysis
Northern blot analyses were performed for detection of
specific c-jun and c-fos transcripts. Hybridisation with a
glyceralaldehyde-3-phosphate dehydrogenase (GAPDH)
probe was carried out for relative quantification of mRNA
levels. Total cellular RNA was isolated by the guanidine
isothiocyanate method and acid phenol extraction (Chomc-
zynski and Sacchi, 1987). Cellular RNA (20 Mg) was size-
fractionated by electrophoresis using 1.5% denaturing
formaldehyde-agarose gels, then transferred to Hybond
N+ nylon membranes (Amersham Buchler, Braunschweig,
Germany) by capillary blotting. Filters were sequentially
hybridised with probes encompassing 1.1 kb of the mouse c-
jun gene, 1.4 kb of the mouse c-fos gene and 210 bp of the
human GAPDH gene; all probes were radiolabelled with
[C_-32P]dATP (Hartmann Analytic, Braunschweig, Germany)
by random hexamer priming (Feinberg and Vogelstein, 1983).
Three x 106 c.p.m. of labelled probe was used per ml of
hybridisation solution [1% bovine serum albumin (BSA),
1 mM disodium EDTA, 250 mM disodium hydrogen phos-
phate heptahydrate, 7% sodium dodecyl sulphate (SDS); all
purchased from Sigma]. Hybridisation was performed at
65°C for 12 h in glass tubes by continuous rotation.
Membranes were washed twice at 65°C for 10 min each in
a wash buffer (1 mM disodium EDTA, 250 mM disodium
hydrogen phosphate heptahydrate, 1% SDS; all purchased
from Sigma) to remove unspecifically bound nucleotides.
Using amplifying screens, blots were exposed to Kodak X-
OMAT AR films (Linhardt, Munich, Germany) at -80°C
for up to 2 days.
Preparation of cell extracts
Whole cell extracts were prepared from 5 x 106 cells.
Monolayer cultures were washed twice with ice-cold PBS
and scraped from the plates with a rubber spatula.
Harvested cells were centrifuged for 10 min at 500 g at
4°C. Following a single wash with ice-cold PBS, cleared cells
were resuspended in 50 ,ul of lysis buffer [20 mM Hepes
potassium hydroxide (KOH), pH7.5, 350 mM potassium
chloride, 1 mM magnesium chloride, 0.5 mM EDTA, 0.1 mM
EGTA, 5 mM dithiothreitol (DTT), 10 Mg ml-' leupeptin,
10 Mg ml-' aprotinin, 0.5% (v/v) of a saturated phenyl-
methylsulphonyl fluoride (PMSF) solution in ethanol, 20%
(v/v) glycerol and 1% (v/v) Nonidet P 40]. After a 15 min
incubation on ice, the lysate was centrifuged in a precooled
microfuge for 20 min at 14 000 r.p.m. The resulting
supernatant was diluted with one volume of buffer H
[20 mM Hepes/potassium hydroxide pH 7.9, 0.2 mM EDTA
and 20% (v/v) glycerol] to reduce salt concentration (all
reagents purchased from Sigma). For all samples, the
amount of protein was determined by a Bradford
microassay procedure (BioRad, Munich, Germany).
Electrophoretic mobility shift assay
In order to detect the DNA-binding activity of transcription
factor AP-1, we used double-stranded (ds) DNA oligonucleo-
tides that encompassed the palindromic AP-1 consensus
sequence 5'-TTCCGGCTGACTCATCAAGCG-3' (pur-
chased from Promega, Heidelberg, Germany). Oligonucleo-
tides were labelled via T4 polynucleotide kinase and
[y-32P]ATP (Hartmann Analytic, Braunschweig, Germany)
phosphorylating free 5'-hydroxy groups. DNA protein-
binding reactions were carried out in a 20 Ml reaction
volume containing 1-3 Ml of whole cell extracts (3 Mg of
protein). DNA-binding was initiated by the addition of
protein extracts to a mix containing 1-2.5 Mg of poly (dl-
dC), 2 Mug BSA as a carrier, 2 Ml of a 10x binding buffer
[100 mM Tris-HCl, pH 7.5, 500 mM sodium chloride, 10 mM
EDTA, 50% (v/v) glycerol, 2 mM DTT, 2 pl 1% (v/v)
Nonidet P 40] (Sigma), and approximately 10 000 c.p.m. of a
y-32P-labelled dsDNA probe with a specific activity not less
than 3000 Ci mmol-'. After 30 min at room temperature, the
samples were loaded on a 4% non-denaturing polyacrylamide
gel in 0.5 x Tris-borate-EDTA buffer. Electrophoresis was
performed in a vertical EMSA system (AGS, Heidelberg,
Germany) at 15 V cm-' for 1.5 h. Gels were dried at 80°C
for 30 min and then exposed for autoradiography.
Results
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of PDT-induced IL-6 gene expression (Kick et al., 1995). The
present investigation proposed to elucidate the regulation of
the AP-1 transcription factor genes c-jun and c-fos by
photodynamic treatment. The same cell line and photo-
sensitisation conditions were tested that were previously
proven to be efficient in the activation of IL-6 gene
expression and AP-1 DNA-binding.
Thus, for the first set of experiments, HeLa cells (5 x 106)
were incubated with Photofrin at a concentration of
1 ig ml-' for 1 h, then illuminated with monochromatic
(630 nm) light at a dose of 4 J cm-2. Total RNA was
harvested at different points in time following irradiation.
The response to phorbol ester TPA (100 ng ml-') that
induces comparable levels of IL-6 mRNA and protein
(Kick et al., 1995) and c-jun and c-fos via the protein kinase
C pathway was determined as a reference. Thirty minutes
after photodynamic treatment, mRNA levels of c-jun were
already significantly increased, reaching a plateau of
maximum levels after 1 to 4 h (Figure 1). Up-regulation of
c-jun mRNA by PDT was much stronger than by TPA
stimulation. In contrast TPA treatment led to a stronger, but
more transient induction of c-fos mRNA expression.
Surprisingly, activation of both proto-oncogenes was clearly
prolonged following photodynamic treatment and was still
detectable after 8 h. Accumulation of c-jun and c-fos mRNA
was dose-dependent and led to maximum amounts of
transcripts at the photosensitiser concentration and illumina-
tion conditions used above for kinetics studies. Specific
mRNA signals could not be detected in untreated cells or
following treatment with either Photofrin or laser light alone
(data not shown).
In order to determine whether the up-regulation of c-jun
and c-fos mRNA levels is caused by induction oftranscription,
HeLa cells were incubated for 2 h with the transcriptional
inhibitor actinomycin D (10 ,g ml-') before PDT. As shown
in Figure 2, PDT could not induce c-jun or c-fos mRNA
significantly in cells without associated transcriptional activity
(lane 3). To define whether the stability of c-jun and c-fos
mRNA is altered by PDT, HeLa cells were treated with TPA
or PDT, then incubated with actinomycin D (act-D) 1 h after
activation to stop further transcription. Cells were harvested
immediately after the addition of actinomycin D (Figure 2,
lanes 4 and 9) and 30 min, 1 h, 2 h and 4 h thereafter. In TPA-
treated cells, c-jun and c-fos mRNA decreased, then
disappeared 1 h after adding actinomycin D (Figure 2, lanes
4 to 8). By comparison, following PDT both transcripts
showed signals up to 4 h after the addition of actinomycin D
(Figure 2, lanes 9 to 13). This result demonstrates that PDT-
mediated induction of c-jun and c-fos mRNA is regulated by
the activation of transcription and a prolongation of the
mRNA half-life.
TPA
To study further whether PDT-induced c-jun and c-fos
mRNA expression is dependent on de novo protein synthesis,
HeLa cells were treated with PDT in both the presence and
absence of cycloheximide, an inhibitor of translation. At
concentrations that efficiently inhibit protein synthesis,
cycloheximide led to a superinduction of c-jun and c-fos
mRNA (Figure 3, lane 4) with about the same high amounts
as upon stimulation by the combination of PDT and
cycloheximide (lane 8). Thus, conclusions concerning the
necessity of de novo protein synthesis could not be drawn
from this experiment. However, the early initiation of c-jun
and c-fos mRNA induction by PDT within 30 min indirectly
indicates that de novo protein synthesis of transcription
factors is not involved in the initial step.
Since photodynamic action is caused by oxidative stress,
we were prompted to explore the influence of antioxidants on
PDT-mediated mRNA uptake. Particularly pyrrolidine
dithiocarbamate (PDTC) and N-acetyl-L-cysteine (NAC)
were tested in multiple studies for efficient radical scavenging
at non-cytotoxic concentrations (Schreck et al., 1992;
Aruoma et al., 1989; Burgunder et al., 1989). In our in vitro
system, PDTC (100,M) led to induction of c-jun and c-fos
mRNA expression (Figure 3, lane 2). This finding concurs
with a previous study that found AP-1 active under both
oxidant and antioxidant conditions (Meyer et al., 1993). After
exposure to NAC (30 mM), only very weak signals were
detectable (Figure 3, lane 3), but both antioxidants
preferentially induced c-fos transcripts. Interestingly, c-jun
mRNA induction upon PDT was reduced by PDTC and
NAC, and for the latter c-jun was selectively suppressed
(lanes 5 to 7). Thus, it appeared that c-jun expression is
mainly caused by the oxidative potential of PDT and could
be regarded as an oxidative stress-responsive member of the
AP-1 transcription factor family. However, c-fos appeared to
be much more strongly activated at the mRNA level under
antioxidant conditions.
In order to analyse if the strong and prolonged expression
of c-jun and c-fos mRNA by PDT is paralleled by an
increased AP-1 DNA-binding activity, protein extracts were
prepared at various points in time after photodynamic
treatment. Again, TPA stimulation was used as a control.
Nuclear extracts were incubated with a 32P-labelled dsDNA
oligonucleotide encompassing the AP-1 consensus sequence.
For a comparison at the level of AP-l-binding activity,
mobility shift assays were carried out with equal amounts of
extracted proteins. An increased AP-1 DNA-binding activity
could be detected as early as 15 min following PDT or
phorbol ester stimulation (data not shown), and strongest
activity was observed after 4 h (Figure 4). At that point in
time, AP-1 protein was barely detectable in extracts of
untreated HeLa cells (Figure 4, lane 1), but the binding was
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0 0.5 1 2 4 8 0 0.5 1 2 4 8
c-jun
c-fos
GAPDH
Figure 1 Kinetics of c-fos and c-jun mRNA induction in HeLa cells by PDT in comparison with stimulation by TPA. Cells
(5 x 106) were treated with 1 Mgml - Photofrin and illuminated with monochromatic light of 630 nm (4Jcm-2) or incubated with
100 ngml -TPA for mitogenic stimulation. The HeLa cells were harvested at the indicated points in time (in h) after treatment. C-
jun and c-fos mRNA was analysed by hybridisation with specific cDNA probes. For relative quantification of mRNA levels,
hybridisation with a GAPDH-specific probe was performed after complete stripping of the probes used previously. An
autoradiogram is shown.
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Figure 2 C-jun and c-fos mRNA accumulation by PDT owing to
transcriptional activation (lanes 1-3) and mRNA stabilisation
(lanes 4-13). Total RNA from HeLa cells was isolated 1 h after
PDT with 1 Mgml-1 Photofrin and 4Jcm-2 (lanes 2 and 3).
Incubation with actinomycin D (act-D; 10 gml-F) 2h before
photosensitisation (lane 3), and of actinomycin D (act-D;
IOpgml-1) lh after treatment by TPA (lOOngml-; lanes 4-
8) or PDT (lanes 9-13) was performed. Total RNA was isolated
immediately (0), 0.5, 1, 2 and 4h after the addition of
actinomycin D. The results for the specific mRNA signals of c-
jun, c-fos and GAPDH as quantitative control are depicted.
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Figure 3 Effects of antioxidant treatment and inhibition of
protein synthesis on the induction of c-jun and c-fos mRNA
expression by PDT in HeLa cells. For antioxidant treatment,
PDTC was applied at a concentration of 100gm and NAC at a
concentration of 30mM. Inhibition of protein synthesis was
induced by cycloheximide (lOpgml-i). For co-incubation
experiments, PDTC and NAC were added 1.5h and cyclohex-
imide 0.5h before light application. Total cellular RNA of HeLa
cells was isolated 1h after PDT (ljugml-l Photofrin; 4Jcm2)
and analysed as described in Figure 1.
strongly induced by TPA stimulation (lane 3). The same
photodynamic treatment (Photofrin: 1 jug ml-'; light:
4 J cm-2) that led to c-jun and c-fos mRNA expression
resulted in activation of AP-1 DNA-binding (Figure 4, lane
2). Despite the relatively strong and prolonged c-jun and c-fos
mRNA induction upon PDT, stimulation by TPA was more
efficient in inducing AP-1 activities at the level of DNA-
binding.
The antioxidant PDTC was shown to activate transcrip-
tion factor AP-1 at the transcriptional and post-translational
level (Meyer et al., 1993). Accordingly, we detected an
increased AP-1 DNA-binding activity following antioxidant
treatment (Figure 4, lane 6). Interestingly, the strong AP-1
activity upon PDTC addition was markedly reduced if anti-
oxidant treatment was combined with photodynamic treat-
ment (Figure 4, lanes 6 and 7) at conditions that otherwise
independently led to AP-1 activation (lane 2).
The DNA-binding activity induced by TPA was also
reduced if phorbol ester stimulation was combined with
photodynamic treatment. The addition of TPA 15 min after
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Figure 4 Induction of AP-l DNA-binding in HeLa cells. For
electrophorectic mobility shift assay (EMSA), a radioactive
labelled dsDNA oligonucleotide comprising the AP-l canonical
consensus sequence motif was incubated with equal amounts of
protein extracts from HeLa cells. Cells (5 x 106) were treated by
PDT (1 jugml Photofrin; light: 4Jcm 2 and 630nm), TPA
(100ngml -), PDTC (100gM) or kept in medium without further
treatment (Co). Co-stimulation with TPA was performed 15min
after (PDT+TPA) or before (TPA +PDT) photodynamic
treatment. PDTC was added 1.5h before illumination. The
fluorogram of a native gel is shown. The position of the protein
DNA complex containing AP-l is indicated with a filled
arrowhead, whereas the free radiolabelled oligonucleotide is
marked with an open triangle. Exposition of the autoradiogram
was performed for 15h at-80°C with an intensifier screen.
(Figure 4, lane 4) and 15 min before (lane 5) photodynamic
treatment resulted in a reduced binding activity as compared
with TPA stimulation alone (lane 3).
Discussion
In this study, photodynamic treatment of human epithelial
HeLa cells led to rapid and strong induction of c-jun and c-
fos mRNA expression. Both genes were induced by similar
kinetics, but c-jun was much more responsive to PDT.
Striking differences were apparent when kinetics of c-jun and
c-fos gene induction by PDT and TPA were compared. The
prolonged induction of both nuclear oncogenes by photo-
dynamic treatment was in sharp contrast to their transient
activation by the phorbol ester TPA. These results suggest a
specific regulatory modus of immediate early genes by
Photofrin-mediated photosensitisation, predominantly gener-
ating singlet oxygen. Other reactive oxygen intermediates,
such as superoxide anions (Crawford et al., 1988; Shibanuma
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et al.. 1988; Amstad et al., 1992) and hydrogen peroxide
(Nose et al., 1991; Devary et al., 1991), activate c-jun and c-
fos transcnrpts by way of similar kinetics with rapid induction
and immediate down-regulation of mRNA signals, just as
described for the immediate-early gene response to serum or
TPA stimulation. One recent study examined the effects of
photosensitiser-mediated oxidative stress on the activation of
c-jun and c-fos mRNA (Luna et al., 1994). Their results
obtained from RIF-1 cells differ from our human system. The
authors received already increased mRNA levels of c-fos and
c-jun at the time of illumination. The kinetics of gene
activation, which they found to be dependent on PKC, were
similar to the TPA or serum response. This could be
explained by the exchange of the medium with increasing
concentrations of FCS 30 min before (5-10%) and after
(15%) illumination (Luna et al.., 1994; Treisman, 1986).
Regulation of c-jun and c-fos expression after photo-
dynamic treatment alone occurred at both the transcriptional
and post-transcriptional levels. Our mRNA stability studies
clearly demonstrated increased half-life of induced c-jun and
c-fos transcripts after PDT. Thus, mRNA stabilisation of
proto-oncogenes by singlet oxygen might account for the
strong and prolonged induction of c-jun and c-fos.
Degradation of mRNA is described as an important step
ofc-jun and c-fos gene regulation, and is responsible for rapid
restriction of protein synthesis. The turnover of c-fos mRNA
depends on two instability domains, the first located within
the 3' untranslated region of the mRNA and consisting of an
AU-rich sequence element (Shyu et al., 1989; Chen and Shyu.
1994). The second domain is positioned in the transcribed
sequence and referred to as the coding region determinant of
mRNA instability of the c-fos gene (Kabnick and Housman,
1988; Chen et al., 1992). At the same time, AT-rich sequences
of the untranslated region of c-jun may be involved in the
post-transcriptional regulation of the c-jun gene (Hattori et
al., 1988). Oxidative stress resulting from photosensitisation
might interfere with protein behaviour at the described
destabilising sites. with unspecific mRNA-degrading activ-
ities or transcriptional elongation blocks (Plet et al., 1995).
Regarding the fundamental importance of AP-1 vis a vis
cell differentiation and proliferation, it seems likely that
aberrant regulation of any component involved might have
dramatic consequences, such as eventual loss of growth
control and neoplastic transformation. Is deregulated c-jun
and c-fos mRNA expression a prerequisite for neoplastic
transformation by photodynamic therapy? Although there is
evidence for a causal relationship between mRNA stability
and transformation potential, oncogenic activation ofc-jun or
c-fos requires both deregulated expression and structural
changes. To activate the transforming potential of c-fos, a
67 bp element in the 3' non-coding region which leads to
mRNA destabilisation must be deleted (Miller et al., 1984:
Lee et al.. 1988; Meijlink et al.. 1985; Rahmsdorf et al.,
1987). Tumour induction by high-level c-fos expression has
been observed in an animal model; c-fos transgenic mice were
constructed under the control of the metallothionein
promoter and the FBJ 3' LTR, which was necessary to
stabilise the exogenous fos mRNA (Ruither et al., 1989).
Furthermore, it appears insufficient to evaluate the risk of
carcinogenesis by AP-I at the level of mRNA expression,
since there are several post-translational regulatory mechan-
isms and, moreover, synergistic or antagonistic interactions
between AP-1 family members and possibly other transcrip-
tion factors.
In the case of photodynamic treatment, post-translational
regulation also appears to be a powerful mechanism in
controlling AP-1 activity. Although mRNA accumulation by
PDT was stronger and even prolonged in comparison with
phorbol ester stimulation, on the level of protein DNA-
binding, photodynamic treatment was much less efficient.
Apparently, the binding capacity of AP-1 is determined by
regulatory mechanisms other than transcriptional activation
of the nuclear factor genes. According to previous reports,
AP-1 was shown to be induced under both pro-oxidant and
anti-oxidant conditions (Abate et al., 1990; Xanthoudakis et
al., 1992). Stronger DNA-binding was caused by the anti-
oxidant state (Meyer et al.. 1993; Schenk et al., 1994; Li and
Jaiswal, 1994). Superoxide anions and hydrogen peroxide
were found to be weak inducers of AP-1 binding (Amstad et
al., 1992; Devary et al., 1991). Reversible oxidation of a
single, conserved cysteine residue located in the DNA-binding
domain of AP-1 proteins modulates their DNA-binding
activity (Abate et al., 1990). Oxidation of these cysteine
sites inhibits the DNA-binding activity of AP-1 (Abate et al.,
1990; Bannister et al., 1991; Frame et al., 1991). Ref-I (redox
factor 1), a DNA repair protein, was found to reactivate in
vitro oxidised AP-1 by reducing this cysteine residue
(Xanthoudakis et al., 1992). Singlet oxygen-mediated redox
regulation of AP-1 binding could therefore explain the
discrepancy between strong mRNA induction and weak
DNA-binding of AP-1 after PDT. Furthermore, oxidation
of cysteine residues might be responsible for the down-
regulation of AP-1 DNA-binding induced by the antioxidant
PDTC upon concomitant photodynamic treatment.
As phorbol ester-mediated AP-1 DNA activation is caused
by dephosphorylation (Boyle et al., 1991; Papavassiliou et al.,
1992) and PKC seems not to be involved in PDT-mediated
regulation of AP-1 in HeLa cells (Kick et al., 1995), redox
regulation might be regarded as the dominant pathway of
AP-1 DNA-binding modulated upon PDT. This argument is
strengthened by the fact that activation of AP-1 upon TPA
was suppressed by PDT both before and after the addition of
the phorbol ester. However, there is growing evidence for
AP-1 regulating cytokine gene expression in response to
PDT.
This research has identified Photofrin-mediated photo-
sensitisation as a potent inducer of c-jun and c-fos mRNA
expression but a comparatively weak activator of AP-1
DNA-binding. Mechanisms of PDT-mediated AP-1 regula-
tion differ from mechanisms of activation by other reactive
oxygen intermediates and phorbol esters, thus suggesting a
unique regulatory pathway. It seems unlikely that deregulated
mRNA expression could enhance the potential risk of PDT-
induced carcinogenesis, since AP-1 DNA-binding is tightly
controlled.
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